This milestone provides BioSante our 1st opportunity possibly to declare completion of enrollment in the basic safety research, mentioned Michael Snabes, M.D., Ph.D., BioSante’s senior vice president of medical affairs. We’ve had an exceptionally low quantity of cardiovascular and breasts cancer events to day, and also three prior favorable DMC recommendations. We expect the scholarly research to demonstrate the security of LibiGel in the treated population, whether or not the DMC stops enrollment at 2,500 females or we have to continue enrollment. .. BioSante enrolls 2,500th female in LibiGel Stage III cardiovascular and breasts cancer safety study BioSante Pharmaceuticals, Inc.The company said it had been continuing to increase its initiatives to work closely with medical suppliers in financial plans that try to rein in expenditures and improve care. The insurer also said it likely to have around 290, 000 enrollees in individual insurance at the ultimate end of 2014, with approximately 69,600 of those coming through authorities marketplaces. Cigna said it was seeing indications of higher-than-expected medical costs in its specific business, including wellness law-compliant programs sold through authorities marketplaces and outside .S.